American Brain Tumor Association

People diagnosed with glioblastoma often face difficult treatment decisions and a need for additional treatment options. A new Phase 2 clinical trial is evaluating silevertinib in combination with temozolomide (TMZ) in adults with newly diagnosed glioblastoma with EGFRvIII and unmethylated

At the American Brain Tumor Association, progress begins with people who believe a better future is possible.

That belief takes many forms. It is found in the families who share their stories, the volunteers who give their time, the researchers pursuing new ideas, and the supporters who make thoughtful decisions today that can strengthen the brain tumor commun...

Turning a promising idea in the lab into an actual clinical trial for patients is one of the hardest and most important steps in cancer research. It’s a gap the American Brain Tumor Association (ABTA) exists to help close through its array of research grant programs.

Dr. Gary Kohanbash, an Associate Professor of Neurological Surgery and Immunology at the University...

Every gift to the American Brain Tumor Association (ABTA), no matter the size, fuels research, supports patients, and brings hope to families facing a brain tumor diagnosis.

Whether you’re looking to stretch your impact, maximize tax benefits, or simply make your giving easier to manage, there’s a giving option for...

August is National Make-a-Will Month, an opportunity to think about the future and make sure your wishes are clearly documented.

A will is an important part of planning for yourself and the people you care about. It can provide clarity for loved ones, outline how you would like your assets handled, and help ensure that the decisions you’ve made are understood.